Hepatic deposition of fibronectin and types I and III collagen also decreased, alongside with reductions in reactive oxygen species and myeloperoxidase levels, which are key contributors to fibrogenesis and portal hypertension (37). This evidence concerns the gene FN1 and liver disorder.